- Myasthenia Gravis Insights
- Posts
- Myasthenia Gravis Insights
 | ||||||||||||
Exciting News! HealthSpotlight is now AllMyHealth Wondering why we have a brand new look? We have exciting news - HealthSpotlight has merged with and rebranded as AllMyHealth. Our shared commitment to supporting rare disease communities with trusted resources and advocacy remains as strong as ever - now under a unified name that reflects our patient-first values. We collaborate with patient support groups to create advocacy materials and amplify community news and events. Want to work with us? Find out more here | ||||||||||||
Top StoriesImproved Mouse Model for Myasthenia Gravis Research Researchers developed a new mouse model for studying myasthenia gravis, aiming to reduce animal discomfort while maintaining effectiveness in simulating the condition's symptoms and immune responses. Read More →High Lactic Acid Levels Predict Post-Thymectomy Crisis Elevated lactic acid levels after thymus removal surgery can indicate a higher risk of severe muscle weakness and breathing problems in people with myasthenia gravis. Monitoring these levels may help doctors identify patients at risk. Read More →MG Onset More Common in Summer Researchers found that people with myasthenia gravis are more likely to experience symptom onset during the summer months, possibly linked to higher temperatures. This discovery could help better understand the condition's triggers. Read More → | ||||||||||||
Latest ResearchIn a recent case study by Santarosa & Cartwright (2025), a 4-year-old girl with a rare subtype of myasthenia gravis was treated with rituximab, a medication not commonly used for young children with this condition. The girl's subtype, known as MuSK myasthenia gravis, is particularly severe and often does not respond well to traditional treatments. The use of rituximab in this case led to a favorable outcome, with the young patient showing signs of remission. This suggests that rituximab could be a safe and effective treatment option for pediatric patients with MuSK myasthenia gravis, even though it is not typically used for children so young. Santarosa & Cartwright's report highlights the potential for rituximab to change the way this rare condition is managed in young children. | ||||||||||||
Community News
How does myasthenia gravis impact your daily life? 
🎉 Join us in wishing a very happy birthday to Megan Choate, a valued member of our Board of Directors! 🥳  | ||||||||||||
Upcoming Events | ||||||||||||
| ||||||||||||
Click Here to Join Our CommunityJoin Our Waitlist | ||||||||||||
More Info 
Add to Calendar 